Viking Therapeutics VKTX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's shares (diluted)?
- Viking Therapeutics (VKTX) reported shares (diluted) of 115.6M in Q1 2026.
- How has Viking Therapeutics's shares (diluted) changed year-over-year?
- Viking Therapeutics's shares (diluted) increased by 3.1% year-over-year, from 112.1M to 115.6M.
- What is the long-term trend for Viking Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Viking Therapeutics's shares (diluted) has grown at a 9.9% compound annual growth rate (CAGR), from 307.9M to 449.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.